No evidence for an association between the -36A>C phospholamban gene polymorphism and a worse prognosis in heart failure

BMC Cardiovascular Disorders

Volumn 9, Issue , 2009, Pages

  Santos, Diogo G B ^a   Medeiros, Alessandra ^a   Brum, Patrícia C ^a   Mill, José G ^b   Mansur, Alfredo J ^a   Krieger, José E ^a   Pereira, Alexandre C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLAMBAN; CALCIUM BINDING PROTEIN;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; FUNCTIONAL STATUS; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEART FAILURE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEOTIDE SEQUENCE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; AGED; CASE CONTROL STUDY; DISEASE COURSE; GENETIC POLYMORPHISM; GENETICS; HEART LEFT VENTRICLE FUNCTION; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TIME;

ADULT; AGED; BRAZIL; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HEART FAILURE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 69949109095     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-9-33     Document Type: Article

References (21)

1. O'Connell JB Bristow MR Economic impact of heart failure in the United States: Time for a different approach J Heart Lung Transplant 1994, 13(4):S107-112. 7947865
2. Filho FMA Epidemiologia da Insuficiência Cardíaca Insuficiência Cardíaca São Paulo: Segmento Barretto ACP, Bocchi EA 2003:13-22.
3. Codd MB Sugrue DD Gersh BJ Melton LJ 3rd Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984 Circulation 1989, 80(3):564-572. 2766509
4. Maron BJ Towbin JA Thiene G Antzelevitch C Corrado D Arnett D Moss AJ Seidman CE Young JB Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 2006, 113(14):1807-1816. 10.1161/CIRCULATIONAHA.106.174287 16567565
5. Bowles KR Bowles NE Genetics of inherited cardiomyopathies Expert Rev Cardiovasc Ther 2004, 2(5):683-697. 10.1586/14779072.2.5.683 15350170
6. Haghighi K Gregory KN Kranias EG Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy Biochem Biophys Res Commun 2004, 322(4):1214-1222. 10.1016/j.bbrc.2004.07.164 15336969
7. Chiu C Tebo M Ingles J Yeates L Arthur JW Lind JM Semsarian C Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy J Mol Cell Cardiol 2007, 43(3):337-343. 10.1016/ j.yjmcc.2007.06.009 17655857
8. Medin M Hermida-Prieto M Monserrat L Laredo R Rodriguez-Rey JC Fernandez X Castro-Beiras A Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation Eur J Heart Fail 2007, 9(1):37-43. 10.1016/j.ejheart.2006.04.007 16829191
9. Koss KL Kranias EG Phospholamban: A prominent regulator of myocardial contractility Circ Res 1996, 79(6):1059-1063. 8943944
10. Schmitt JP Kamisago M Asahi M Li GH Ahmad F Mende U Kranias EG MacLennan DH Seidman JG Seidman CE Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban Science 2003, 299(5611):1410-1413. 10.1126/science.1081578 12610310
11. Haghighi K Kolokathis F Pater L Lynch RA Asahi M Gramolini AO Fan GC Tsiapras D Hahn HS Adamopoulos S et al Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human J Clin Invest 2003, 111(6):869-876. 153772 12639993
12. Haghighi K Kolokathis F Gramolini AO Waggoner JR Pater L Lynch RA Fan GC Tsiapras D Parekh RR Dorn GW 2nd et al A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy Proc Natl Acad Sci USA 2006, 103(5):1388-1393. 1360586 16432188 10.1073/pnas.0510519103
13. Posch MG Perrot A Geier C Boldt LH Schmidt G Lehmkuhl HB Hetzer R Dietz R Gutberlet M Haverkamp W et al Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes Heart Rhythm 2009, 6(4):480-486. 10.1016/j.hrthm.2009.01.016 19324307
14. Haghighi K Chen G Sato Y Fan GC He S Kolokathis F Pater L Paraskevaidis I Jones WK Dorn GW 2nd et al A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids Hum Mutat 2008, 29(5):640-647. 10.1002/humu.20692 18241046
15. McKee PA Castelli WP McNamara PM Kannel WB The natural history of congestive heart failure: The Framingham study N Engl J Med 1971, 285(26):1441-1446. 5122894
16. Richardson P McKenna W Bristow M Maisch B Mautner B O'Connell J Olsen E Thiene G Goodwin J Gyarfas I et al Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies Circulation 1996, 93(5):841-842. 8598070
17. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies Br Heart J 1980, 44(6):672-673. 482464 7459150 10.1136/hrt.44.6.672
18. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators N Engl J Med 1991, 325(5):293-302. 2057034
19. Pereira AC Sposito AC Mota GF Cunha RS Herkenhoff FL Mill JG Krieger JE Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: New evidence for a direct effect of lipids in arterial blood pressure Atherosclerosis 2006, 184(1):193-200. 10.1016/ j.atherosclerosis.2005.03.035 15916766
20. Sahn DJ DeMaria A Kisslo J Weyman A Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements Circulation 1978, 58(6):1072-1083. 709763
21. Miller SA Dykes DD Polesky HF A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988, 16(3):1215. 334765 3344216 10.1093/nar/16.3.1215